References
- 1. Weber F, Dan Y. Circuit-based interrogation of sleep control. Nature. 2016, 538 (7623): 51-59.
- 2. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010, 11 (8): 589-99.
- 3. Datta S. Cellular and chemical neuroscience of mammalian sleep. Sleep Med. 2010, 11 (5): 431-40.
- 4. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006, 10 (1): 49-62.
- 5. Amici R, Bastianini S, Berteotti C et al. Sleep and bodily functions: the physiological interplay between body homeostasis and sleep homeostasis. Arch Ital Biol. 2014, 152 (2-3): 66-78.
- 6. Besedovsky L, Lange T, Haack M. The Sleep-Immune Crosstalk in Health and Disease. Physiol Rev. 2019, 99 (3): 1325-1380.
- 7. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007, 11 (3): 163-78.
- 8. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011, 32 (12): 1484-92.
- 9. Dettoni JL, Consolim-Colombo FM, Drager LF et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985). 2012, 113 (2): 232-6.
- 10. Pace-Schott EF, Germain A, Milad MR. Effects of sleep on memory for conditioned fear and fear extinction. Psychol Bull. 2015, 141 (4): 835-57.
- 11. Jîtcă G, Ősz BE, Tero-Vescan A, Vari CE. Psychoactive Drugs-From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review. Antioxidants. 2021, 10 (3): 381.
- 12. Jîtcă G, Ősz BE, Tero-Vescan A et al. Positive Aspects of Oxidative Stress at Different Levels of the Human Body: A Review. Antioxidants. 2022, 11 (3): 572.
- 13. Rahal A, Kumar A, Singh V et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014: 761264.
- 14. Atrooz F, Liu H, Kochi C, Salim S. Early Life Sleep Deprivation: Role of Oxido-Inflammatory Processes. Neuroscience. 2019, 406: 22-37.
- 15. Stefanescu C, Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord. 2012, 143 (1-3): 34-8.
- 16. Guney E, Fatih Ceylan M, Tektas A et al. Oxidative stress in children and adolescents with anxiety disorders. J Affect Disord. 2014, 156: 62-6.
- 17. Reimund, Eric. The free radical flux theory of sleep. Medical hypotheses, 1994, 43 (4): 231-3.
- 18. Ramanathan L, Gulyani S, Nienhuis R, Siegel JM. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport. 2002, 13 (11): 1387-90.
- 19. Everson CA, Laatsch CD, Hogg N. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol. 2005, 288 (2): R374-83.
- 20. Ramanathan L, Hu S, Frautschy SA, Siegel JM. Short-term total sleep deprivation in the rat increases antioxidant responses in multiple brain regions without impairing spontaneous alternation behavior. Behav Brain Res. 2010, 207 (2): 305-9.
- 21. Solanki N, Atrooz F, Asghar S, Salim S. Tempol protects sleep-deprivation induced behavioral deficits in aggressive male Long-Evans
- 22. Irwin MR, Wang M, Ribeiro D et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008, 64 (6): 538-40.
- 23. Irwin MR, Witarama T, Caudill M, Olmstead R, Breen EC. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun. 2015, 47: 86-92.
- 24. van Leeuwen WM, Lehto M, Karisola P et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One. 2009, 4 (2): e4589.
- 25. Wright KP Jr, Drake AL, Frey DJ, Fleshner M, Desouza CA, Gronfier C, Czeisler CA. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun. 2015, 47: 24-34.
- 26. Chennaoui M, Gomez-Merino D, Drogou C et al. Effects of exercise on brain and peripheral inflammatory biomarkers induced by total sleep deprivation in rats. J Inflamm (Lond). 2015, 12: 56.
- 27. Nahirnyj A, Livne-Bar I, Guo X, Sivak JM. ROS detoxification and proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activation. PLoS One. 2013, 8 (12): e83049.
- 28. Kraus SS, Rabin LA. Sleep America: managing the crisis of adult chronic insomnia and associated conditions. J Affect Disord. 2012, 138 (3): 192-212.
- 29. ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod. 2017, 103: 1-36.
- 30. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008, 153 (2): 199-215.
- 31. Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and orthosteric pharmacology of cannabidiol and cannabidi- ol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br J Pharmacol. 2019, 176: 1455–1146.
- 32. Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010, 160 (3): 530-43.
- 33. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018, 49: 12-19.
- 34. Tura M, Mandrioli M, Gallina Toschi T. Preliminary study: comparison of anti- oxidant activity of cannabidiol (CBD) and α-tocopherol added to refined olive and sunflower oils. Molecules. 2019, 24: 1–15.
- 35. De Briyne N, Holmes D, Sandler I et al. Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know? Animals. 2021, 11 (3): 892.
- 36. Romanian Parliament, Law No nr.339/2005 on the legal regime for narcotic and psychotropic plants, substances and preparations, Romanian Official Gazette, nr. 1095/05.12.2005.
- 37. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology. 2004, 24 (3): 305-313.
- 38. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981, 21 (S1): 417S-427S.
- 39. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Braz J Psychiatry. 2008, 30 (3): 271-80.
- 40. Chagas MH, Crippa JA, Zuardi AW et al. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. J Psychopharmacol. 2013, 27 (3): 312-6.
- 41. Hsiao YT, Yi PL, Li CL, Chang FC. Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology. 2012, 62 (1): 373-84.
- 42. Shannon S, Opila-Lehman J. Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report. Integr Med (Encinitas). 2015, 14 (6): 31-5.
- 43. Cooray R, Gupta V, Suphioglu C. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review. Mol Neurobiol. 2020, 57 (11): 4878-4890.
- 44. Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson’s disease. Lancet Neurol. 2021, 20 (7): 559-572.
- 45. Chagas MH, Eckeli AL, Zuardi AW et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014, 39 (5): 564-6.
- 46. Raskind MA, Peterson K, Williams T et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013, 170 (9): 1003-10.
- 47. Fogaça MV, Reis FM, Campos AC, Guimarães FS. Effects of intraprelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropsychopharmacol. 2014, 24 (3): 410-9.
- 48. Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015, 16 (12): 705-18.
- 49. Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009, 15 (1): 84-8.
- 50. Ferguson, G and Ware Ma. Review Article: Sleep, Pain and Cannabis. Journal of sleep disorders and therapy. 2015, 4: 1-5.
- 51. Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010 Feb 1;110(2):604-10.